Equities

Elan Corp

Elan Corp

Actions
Health CareHealth Care Providers
  • Price (JPY)710.00
  • Today's Change-9.00 / -1.25%
  • Shares traded236.80k
  • 1 Year change-26.73%
  • Beta1.4316
Data delayed at least 20 minutes, as of Nov 21 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Elan Corp grew revenues 14.23% from 36.26bn to 41.43bn while net income improved 20.94% from 2.08bn to 2.52bn.
Gross margin23.06%
Net profit margin5.37%
Operating margin7.99%
Return on assets13.14%
Return on equity22.31%
Return on investment22.04%
More ▼

Cash flow in JPYView more

In 2023, cash reserves at Elan Corp fell by 547.46m. However, the company earned 1.78bn from its operations for a Cash Flow Margin of 4.30%. In addition the company used 1.66bn on investing activities and also paid 667.09m in financing cash flows.
Cash flow per share49.83
Price/Cash flow per share14.46
Book value per share196.49
Tangible book value per share181.88
More ▼

Balance sheet in JPYView more

Elan Corp uses little debt in its capital structure as supported by a debt to capital ratio of 1.09%.
Current ratio1.96
Quick ratio1.72
Total debt/total equity0.011
Total debt/total capital0.0109
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 18.18% and 20.93%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Healthcare Facilities industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)0.81%
Div growth rate (5 year)30.01%
Payout ratio (TTM)31.99%
EPS growth(5 years)23.88
EPS (TTM) vs
TTM 1 year ago
11.53
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.